Prostate specific antigen half-time and prostate specific antigen doubling time as predictors of response to androgen deprivation therapy for metastatic prostate cancer. [electronic resource]
- The Journal of urology Jun 2009
- 2520-4; discussion 2525 p. digital
Publication Type: Journal Article
1527-3792
10.1016/j.juro.2009.01.104 doi
Aged Androgen Antagonists--therapeutic use Castration Gonadotropin-Releasing Hormone--agonists Humans Male Neoplasm Metastasis Predictive Value of Tests Prostate-Specific Antigen--blood Prostatic Neoplasms--blood Time Factors